Private equity investment in healthcare hit a record $191 billion in 2025. But as more investors crowd into the sector, competition for high-quality assets is intensifying, driving up prices and increasing pressure to deliver successful exits. The post Private Equity’s Healthcare Boom Is Getting More Crowded appeared first on MedCity News.
Growth without structural discipline creates risk. And the risk that has gone largely unexamined in the DPC advocacy space is the one that matters most to the broader healthcare system: what happens to insurance risk pools when healthy lives migrate out of them? The post DPC Is Scaling — The Financing Architecture Isn’t Ready appeared…
KFF’s Tracking Poll on Health Information and Trust finds that just over half of adults use social media for health information and advice at least occasionally but fewer than half say they find “most” or “some” of the information they see on each platform trustworthy.
In October 2024, the Centers for Medicare and Medicaid Services (CMS) approved the first ever Section 1115 waiver demonstration amendments that would allow Medicaid and CHIP coverage of traditional health care practices for American Indian or Alaska Native (AIAN) people in Arizona, California, New Mexico, and Oregon. This Waiver Watch reviews disparities in health and…
Johnson & Johnson is suing the federal agencies overseeing the 340B program that makes discounted medicines more accessible to uninsured and underserved patients. J&J contends the Health Resources Services Administration can’t legally oppose its plan to implement a new rebate plan for certain 340B drugs. The post Johnson & Johnson Takes the 340B Drug Rebate…
Through a new partnership, employees of BetterHelp’s employer clients can access Talkiatry’s psychiatry services on an in-network basis at no extra cost. The post BetterHelp, Talkiatry Collaborate To Offer Psychiatric Services to Employers appeared first on MedCity News.
To shift wearables from wellness tools to useful drivers of disease management, the data they generate must be as trustworthy as it is plentiful. Clear frameworks that govern how information is gathered and used are needed, along with standards for the accuracy and reliability of devices The post Stronger Data Governance and Reliability Standards Needed…
Novartis malaria drug Coartem has expanded its approval to include babies. The combination drug, originally formulated as a tablet, has a new dose strength and formulation designed for treating newborns and young infants who develop malarial infections. The post Novartis Drug Becomes First Malaria Therapy for Newborns and Infants appeared first on MedCity News.
Israeli clinical AI startup Aidoc raised $150 million in a funding round led by General Catalyst and Square Peg, with participation from four U.S. health systems. The company has more than 150 health system customers. The post Aidoc Rakes In $150M for Its Clinical Decision Support AI appeared first on MedCity News.
OpenEvidence’s $12 billion valuation reflects investor confidence in its bottom-up, doctor-first model. It has driven rapid adoption, with more than 430,000 clinicians using the startup’s free AI medical search tool regularly. That scale is paired with targeted pharmaceutical advertising that’s already pushed the company past a $100 million revenue run rate. The post Thunderstruck By…